Boehringer Ingelheim · 2 months ago
Executive Director, ExpMED Oncology Targeted Therapy (Remote)
United States
Full-time
Remote
Director/Executive
$250K/yr - $394K/yr
10+ years expBoehringer Ingelheim is a global leader in healthcare dedicated to improving lives through innovation. They are seeking an Executive Director for Experimental Medicine Oncology Targeted Therapy to provide medical strategic leadership and oversight in early clinical development of immunotherapy. The role involves managing teams, ensuring alignment on scientific strategies, and making key decisions in clinical evaluations.
BiotechnologyHealthcarePharmaceuticalHealth CareMedical
No H1B
Responsibilities
In collaboration with the Head of ExpMED TA and fellow Associate Heads, exert medical and scientific strategic leadership for the Therapeutic Area, with a focus on assets within his/her area of responsibility
Maintain and spread knowledge of scientific developments, (products, mechanisms, methodologies) competitor strategies and external environment developments within his/her area of responsibility
Ensures alignment regarding scientific platforms, medical communication and publication strategies as well as the Product Maintenance and Optimization strategies for each substance or project under their responsibility as delegated by TA HoEM
Review and approve final Clinical Trial Reports, Clinical Trial Protocols, scientific publications according to established procedures as delegated by the TA HoEM
Ensures the review of the Master Plans, related Clinical Development plans and Clinical Trial Protocols and programmes, by the CEG for each substance or project under their responsibility as delegated by TA HoEM
Key decision maker in internal committee discussions
Serve as a member of the Therapeutic Area Licensing Advisory team, responsible for preliminary, clinical evaluation of in-licensing opportunities and oversight of in-depth in-licensing evaluations as delegated by the TA HoEM
Manage employees belonging to his/her team and establish and maintain adequate standards of people management e.g. Training and personal development, communication, interface definition and processes
Advise, coach and develop his/her teams regarding the preparation of key deliverables within his/her area of responsibility
Support annual international medical budgeting process as delegated by the TA HoEM
Supports and backs TA HoEM according to individually documented delegation of responsibilities
Qualification
Required
MD or PhD from an accredited institution
Sound clinical and scientific experience in Oncology/Early Clinical Development Targeted Therapy with ten to fifteen (10-15) years (combination of hospital, academic and industry experience), inclusive of senior leadership role/s; Clinical / pharma experience in the US a plus
Strong track record of designing trials that delivered milestones such as PoC (Proof of concept)
Expertise in Oncology translational and clinical research with focus on early clinical development (IND enabling activities through Proof of Concept studies), ideally clinical specialization hematology, oncology or organ specialist. Solid relationships with key stakeholders
Sound medical and scientific leadership - maintains team's focus on high priority items even under constantly changing circumstances
Proven success leading global teams preferred
Pragmatic leader that supports and empowers teams to remove hurdles and resolve issues
Ability to act with grace and resilience under pressure
Excellent communication, negotiation and influencing skills
Excellent cross-functional collaboration skills
Full command of English Language
Excellent presentation, training and facilitation skills
Strong track record of interactions with regulatory affairs authority, international societies and other relevant stakeholders
Situational Responsiveness
Deals with Ambiguity
Constantly learns and improves
Advanced Management and Sound Management Skills
Strong leadership skills
Ability to travel globally required
Benefits
Role specific variable or performance based bonus
Other compensation elements
Company
Boehringer Ingelheim
Boehringer Ingelheim is a group of pharmaceutical companies that focuses on prescription medicines and animal health. It is a sub-organization of Boehringer Ingelheim.
Founded in 1885Ingelheim Am Rhein, Rheinland-Pfalz, DEU
10001+ employees
Funding
Current Stage
Late StageLeadership Team
Christian Eckermann
Corp. SVP BioPharma Network
Clemens Twardy
Corporate Vice President, Head of Global Supply Chain and Lifecycle Management Animal Health
Recent News
Labiotech UG
2026-02-07
Company data provided by crunchbase